RACK1 and CIS mediate the degradation of BimEL in cancer cells.

The Journal of Biological Chemistry
Weizhou ZhangLu-Hai Wang

Abstract

RACK1 is a 7-WD motif-containing protein with numerous downstream effectors regulating various cellular functions. Using a yeast two-hybrid screen, we identified dynein light chain 1 as a novel interacting partner of RACK1. Additionally, we demonstrated that RACK1 formed a complex with DLC1 and Bim, specifically BimEL, in the presence of apoptotic agents. Upon paclitaxel treatment, RACK1, DLC1, and CIS mediated the degradation of BimEL through the ElonginB/C-Cullin2-CIS ubiquitin-protein isopeptide ligase complex. We further showed that RACK1 conferred paclitaxel resistance to breast cancer cells in vitro and in vivo. Finally, we observed an inverse correlation between CIS and BimEL levels in both ovarian and breast cancer cell lines and specimens. Our study suggests a role of RACK1 in protecting cancer cells from apoptosis by regulating the degradation of BimEL, which together with CIS could play an important role of drug resistance in chemotherapy.

References

Aug 10, 2000·The American Journal of Pathology·L A O'ReillyA Strasser
Dec 2, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·H BernsE J Battegay
Mar 30, 2001·The Journal of Biological Chemistry·S KamizonoA Yoshimura
Nov 19, 2002·Molecular Pharmacology·Angela McCahillStephen J Yarwood
Jun 24, 2003·Neuron·Girish V PutchaEugene M Johnson
Jul 31, 2003·British Journal of Cancer·M RaccurtM J Waters
Sep 17, 2003·Apoptosis : an International Journal on Programmed Cell Death·F Mollinedo, C Gajate
Oct 7, 2003·The Journal of Biological Chemistry·Andrew SuntersEric W-F Lam
May 4, 2004·Molecular and Cellular Biology·Robert L Kortum, Robert E Lewis
Aug 31, 2004·Nature Structural & Molecular Biology·Jayati SenguptaJoachim Frank
Oct 16, 2004·Proceedings of the National Academy of Sciences of the United States of America·Hisashi HaradaStanley J Korsmeyer
Dec 2, 2004·Biochimica Et Biophysica Acta·Andrew R WillemsMike Tyers
Dec 14, 2004·Cell Death and Differentiation·M AdachiK Imai
Feb 23, 2005·European Journal of Immunology·Patricia Gomez-BougieMartine Amiot
May 19, 2005·Molecular and Cellular Biology·Mauricio J ReginatoJoan S Brugge
Aug 3, 2005·Molecular Cell·Pablo López-BergamiZe'ev Ronai
Nov 12, 2005·The Journal of Biological Chemistry·Xiao-Jun QiPhilip H Howe

❮ Previous
Next ❯

Citations

Jun 3, 2011·Archivum Immunologiae Et Therapiae Experimentalis·Toru Akiyama, Sakae Tanaka
Aug 21, 2013·Trends in Cell Biology·Kaleigh Fernald, Manabu Kurokawa
Oct 17, 2012·Molecular & Cellular Proteomics : MCP·Nicole RachfallGerhard H Braus
Oct 20, 2011·Thyroid : Official Journal of the American Thyroid Association·Line M MyklebustJohan R Lillehaug
Jul 23, 2009·Cancer Research·Grazia AmbrosiniGary K Schwartz
Jun 2, 2012·The Journal of Clinical Investigation·Yuanyuan RuanJianxin Gu
Feb 3, 2009·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Robert Meller
Oct 8, 2011·Cell Communication and Signaling : CCS·David R AdamsPatrick A Kiely
Jul 4, 2012·BMC Veterinary Research·Cécile CampagneGiorgia Egidy
Aug 4, 2012·Critical Reviews in Eukaryotic Gene Expression·Hisashi Harada, Steven Grant
Apr 8, 2015·Pharmacology & Therapeutics·Lixia WangWenyi Wei
Sep 30, 2009·Biochemical and Biophysical Research Communications·Yuanyuan RuanJianxin Gu
Jul 23, 2011·The FEBS Journal·Péter RapaliLászló Nyitray
Dec 3, 2014·Molecular and Cellular Endocrinology·Philip J Jensik, Lydia A Arbogast
Jan 20, 2009·Molecular Cell·Elinor DehanMichele Pagano
Jun 3, 2014·Oncogene·J-J Li, D Xie
Sep 23, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yuki IkebuchiHiroshi Suzuki
Jul 30, 2020·British Journal of Pharmacology·Erica BuosoMarco Racchi
Sep 26, 2015·Oncotarget·Ronit Vogt SionovZvi Granot
Aug 17, 2018·Future Science OA·Jon P DayGeorge S Baillie
May 28, 2010·Electrophoresis·Vibeke H BullBernd Thiede
Feb 27, 2018·Frontiers in Cell and Developmental Biology·Ishita GuptaSameena Khan
Jun 10, 2016·International Journal of Oncology·Xuefeng ZhangQianming Chen
Nov 26, 2009·Molecular Cancer Therapeutics·Toru AkiyamaPeter F M Choong
Nov 5, 2014·Journal of Proteome Research·Karina Taciana SilvaMilton Hércules Guerra Andrade
Dec 17, 2021·Cell Death and Differentiation·Jamie Z RobertsDaniel B Longley

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis